Pfizer (NYSE: PFE) SVP D'Amico sells 3,278 common shares

Rhea-AI Filing Summary

Pfizer Inc officer Jennifer B. D'Amico, SVP & Controller, reported a sale of 3,278 shares of Common Stock on 2026-08-05 at $25.40 per share. Following this open market or private transaction, she directly held 28,611 Pfizer shares.

Insider Trade Summary

Net Seller: 3,278 shares

Net Sell 1 txn

Insider DAMICO JENNIFER B.

Role SVP & Controller

Sold 3,278 shs ($83K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,278	$25.40	$83K

Holdings After Transaction: Common Stock — 28,611 shares (Direct)

Key Figures

Shares sold: 3,278 shares Sale price per share: $25.40 Shares owned after sale: 28,611 shares

3 metrics

Shares sold 3,278 shares Common Stock sold on 2026-08-05

Sale price per share $25.40 Price per share for sale on 2026-08-05

Shares owned after sale 28,611 shares Direct Common Stock ownership following the transaction

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 11:27 AM Accepted by SEC EDGAR 08/06/2026 - 11:26 AM Learn about SEC filing dates

FAQ

What insider transaction did Pfizer (PFE) report from Jennifer B. D'Amico?

Pfizer reported that SVP & Controller Jennifer B. D'Amico sold 3,278 shares of common stock on 2026-08-05 at $25.40 per share. After this transaction, she directly owned 28,611 shares of Pfizer common stock.

At what price did Pfizer (PFE) executive Jennifer B. D'Amico sell her shares?

Jennifer B. D'Amico sold Pfizer common stock at $25.40 per share on 2026-08-05. The reported transaction covered 3,278 shares and was classified as a sale in an open market or private transaction under Form 4.

How many Pfizer (PFE) shares does Jennifer B. D'Amico hold after the reported sale?

After the reported sale, Jennifer B. D'Amico directly holds 28,611 shares of Pfizer common stock. Before this transaction, she owned more shares but disposed of 3,278 shares in the 2026-08-05 sale.

What role does Jennifer B. D'Amico hold at Pfizer (PFE) in this Form 4 filing?

Jennifer B. D'Amico is identified as SVP & Controller of Pfizer in the Form 4 filing. As a corporate officer, her transactions in Pfizer common stock must be reported to the SEC and disclosed to investors.

Was the Pfizer (PFE) Form 4 transaction by Jennifer B. D'Amico a buy or a sell?

The Form 4 shows a sell transaction by Jennifer B. D'Amico. She disposed of 3,278 shares of Pfizer common stock on 2026-08-05, at a reported price of $25.40 per share, and retained 28,611 shares afterward.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DAMICO JENNIFER B.

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Controller

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2026		S		3,278	D	$25.4	28,611	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)